An interventional study of Printed Information Booklet and Umay Mobile Health Application in Infertility, Female Stress and Psychological, sponsored by Atlas University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 21 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Atlas University · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to learn whether a Turkish-language mobile health application (Umay) can reduce fertility-related stress and improve healthy lifestyle behaviours in women diagnosed with infertility who are receiving care at in vitro fertilisation clinics.
The main questions it aims to answer are:
Participants:
This was a pilot, non-randomised controlled trial with pre-test and post-test measurements, conducted between October 2023 and March 2024 in the in vitro fertilisation clinics of two branches of a private hospital in Istanbul, Türkiye.
The Umay application was developed in Turkish for women with infertility. It contains three modules (reproductive health and infertility, healthy lifestyle, and mental well-being) with 33 short videos, a daily plan in which users tick off recommended activities, fertility-oriented yoga videos, and a meditation section with relaxation music and a breathing exercise. Persuasive features, including daily push notifications (morning motivation, a daytime walking reminder and an evening sleep message) and a counter of days of use, were included to support engagement and behaviour change.
The control group received a 32-page printed booklet covering the same three topics. The booklet was reviewed by experts using the Suitability Assessment of Materials.
Eligible women were given a sequential number at enrolment and allocated alternately to the two groups (odd numbers to the application, even numbers to the booklet). Participants who withdrew were replaced, and 16 women per group completed the study. Within-group changes were analysed with the Wilcoxon signed-rank test.
The study was approved by the University of Health Sciences Hamidiye Scientific Research Ethics Committee (approval number 14097, 10 December 2022), and all participants gave written informed consent. The trial was registered retrospectively.
2,085 studies on the registry are indexed under Infertility; 357 are open to participants now.
This study's enrollment of 40 is below the median of 135 across 1,412 interventional studies indexed under Infertility.
Browse Infertility studies →Atlas University is the lead sponsor of 96 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Women used the Turkish-language Umay mobile health application for eight weeks in addition to routine clinical care.
Behavioral: Umay Mobile Health Application
Women received a 32-page printed infertility information booklet with the same content to use for eight weeks in addition to routine clinical care.
Behavioral: Printed Information Booklet
Expert-reviewed printed booklet (32 pages) covering reproductive health and infertility, healthy lifestyle and mental well-being, given at baseline for use over eight weeks.
Smartphone application with three modules (reproductive health and infertility, healthy lifestyle, mental well-being) containing 33 short videos, a daily activity plan with check-boxes, fertility yoga videos, meditation music and a breathing exercise, and three daily push notifications (morning motivation, daytime walking reminder, evening sleep message). Used for eight weeks.
Fertility-related stress (Fertility Problem Inventory)
Measured with the Turkish version of the Fertility Problem Inventory (46 items; total and five subscales: social concern, sexual concern, relationship concern, need for parenthood, rejection of childfree lifestyle). Scores are reported as item means (range 1-6); higher scores indicate greater fertility-related stress.
Time frame: Baseline and 8 weeks
Health-promoting lifestyle (Health-Promoting Lifestyle Profile II)
Measured with the Turkish version of the Health-Promoting Lifestyle Profile II (52 items; total and six subscales: health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, stress management). Scores are reported as item means (range 1-4); higher scores indicate healthier lifestyle behaviours.
Time frame: Baseline and 8 weeks
Usability of the mobile health application
Assessed in the intervention group only with an 11-item yes/no usability questionnaire and open-ended questions about the application.
Time frame: 8 weeks
Plan to share: No — Individual participant data will not be deposited in a public repository. De-identified data are available from the corresponding author on reasonable request.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Atlas University